Showing results (411-420 of 472) with videos related to
Sort By:
Pageof 48
Urologic Oncology|June 9, 2026
Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional CollaborativeRahul K Bansal, Raees Cassim, Ranjeeta Mallick, et al.Cancer Letters|April 9, 2026
Mitochondrial ACSS1 Links Acetate Metabolism to Pyrimidine Biosynthesis in Nutrient-Stressed B-Cell LymphomasJohnvesly Basappa, Aaron R Goldman, Cosimo Lobello, et al.Journal of Geriatric Oncology|February 15, 2026
Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in CanadaLauren Curry, Sunita Ghosh, Erica Arenovich, et al.Prostate Cancer and Prostatic Diseases|February 24, 2022
Real-world utilization and outcomes of docetaxel among older men with metastatic prostate cancer: a retrospective population-based cohort study in CanadaBobby Shayegan, Christopher J D Wallis, Robert J Hamilton, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 30, 2023
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 TrialJames Chih-Hsin Yang, Baohui Han, Emmanuel De La Mora Jiménez, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancerGeoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.Cancer|October 12, 2018
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumSteven M Yip, Connor Wells, Raphael Moreira, et al.Urologic Oncology|February 26, 2022
Real-world use of systemic therapies in men with metastatic castration resistant prostate cancer (mCRPC) in CanadaBobby Shayegan, Christopher J D Wallis, Shawn Malone, et al.Medrxiv : the Preprint Server for Health Sciences|October 14, 2020
Antibody reactivity to SARS-CoV-2 is common in unexposed adults and infants under 6 monthsAbdelilah Majdoubi, Christina Michalski, Sarah E O'Connell, et al.European Urology Focus|November 5, 2021
Outcomes of Cytoreductive Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Real World Data from Canadian CentersAlice Dragomir, Sara Nazha, Simon Tanguay, et al.Pageof 48